Loading...
Stricter FDA Oversight And Pricing Pressures Will Limit Reach
n/a
n/a
AnalystLowTarget's Fair Value
n/a
1Y
112.3%7D
2.2%1Y
112.3%7D
2.2%You can edit this narrative until Aug 29 10:19 PM. Then, changes will post as Updates.
You can edit this narrative until Aug 29 10:19 PM. Then, changes will post as Updates.